BNET Industries
Affymetrix (AFFX) is in the Technology Industry
- Revenue
- Dec 31 2007
- $371.3M
- Profit
- Dec 31 2007
- $12.5M
- Market Cap
- Nov 20 2008
- $167.0M
Latest News and Analysis
Affymetrix, Inc. Q3 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Thank you, sir. Operator instructions Our first question comes from Quintin Lai with Robert W. Baird. Matt – Robert W. Baird Good afternoon. This is actually Matt [ph] in for Quintin. Just two questions actually from me right now. First, I might have missed it...
Zacks Earnings Preview: Deckers Outdoor, JetBlue Airways, Timken and Affymetrix
CHICAGO -- Zacks.com releases the list of companies likely to issue earnings surprises. This week's list includes Deckers Outdoor (Nasdaq: DECK), JetBlue Airways (Nasdaq: JBLU), Timken (NYSE: TKR) and Affymetrix (Nasdaq: AFFX). To see more earnings analysis, visit http://at.zacks.com/?id=3207. Earnings Preview is written by Charles Rotblut, CFA, Senior Market...
Wall Street Journal Selects PhyloChip Developed on the Affymetrix Platform as a Top Technology Innovation
Custom Array Developed by Lawrence Berkeley National Laboratory is Recognized for Its Contribution to Air Quality Testing SANTA CLARA, Calif. -- Affymetrix Inc. (Nasdaq:AFFX) announced today that the PhyloChip, a custom Affymetrix microarray developed by Lawrence Berkeley National Laboratory, won the bronze prize in the 2008 Wall Street Journal...
Three Biotech ETFs: A Way To Follow the 'Smart Money' into Healthcare
Trader Mark submits: One area you can see I've been transitioning into is healthcare. I still don't buy the "technology is a safe haven" thesis, but I have to respect that's where money flow is going. Healthcare I can feel a bit more comfortable with because it's a...
All four IBO indexes defy market turbulence
Disappointing economic news continued to weigh on the US markets this month. On July 31, the US reported second-quarter economic growth of 1.9%, compared to economists' expectations of 2.3%. The US also lowered its GDP estimates for the first quarter of this year and the fourth quarter of 2007 to...
Affymetrix Inc. Q2 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Your first question comes from Tycho Peterson with JPMorgan. Your line is open. Tycho Peterson - JPMorgan Hi, yes. Thanks for taking the call. Steve Fodor Hi, Tycho. Tycho Peterson - JPMorgan I'm going to try to probe a little bit more on the acquisition...
Half-year litigation review: two trial dates approach
In the first of IBO's twice yearly report on new litigation among analytical instrument and laboratory product providers, we take a look at new patent infringement cases, as well as update the latest developments in other cases. Two cases are scheduled to come to trial in the next few months,...
All four IBO indexes follow market's decline
The markets tumbled in June as the Dow Jones Industrial Average, S&P 500 and NASDAQ declined 10.2%, 8.6%, 9.1%, respectively. With rising inflation, record oil prices and a worsening credit markets, even the most optimistic Wall Street pundits dismissed any ideas about a quick recovery in the second half of...
Affymetrix Inc. Q1 2008 Earnings Call Transcript
Question-and-Answer SessionOperator 1 OPERATOR INSTRUCTIONS We'll pause for just a moment to compile the Q&A roster. Your first question comes from Derik De Bruin. Doug Farrell Hello, Derik, how are you? Derik De Bruin - UBS Hi. How are you? Doug Farrell Good, thanks. Derik De Bruin -...
Affymetrix Q4 2007 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Our first question comes from the line of Quentin Lai with Robert W. Baird. Quintin Lai - Robert W. Baird & Company - Inc. The array number that you posted was quite impressive here in the fourth quarter. Could you give...
Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
SANTA CLARA, Calif. -- Affymetrix Inc. (NASDAQ:AFFX) today announced that John Batty, executive vice president and chief financial officer, will provide a company overview at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7th in New York City. A live webcast of the presentation will take...
Illumina, Inc. vs Current Events.
M2 PRESSWIRE-10 January 2008-Market Review: Illumina, Inc. vs Current EventsC1994-2008 M2 COMMUNICATIONS LTD RDATE:10012008 Wednesday brought about a moderate rebound following a Tuesday tumbling amid questions in regards to the strength of the economy and the soundness of upcoming corporate earnings...
Affymetrix patents to be reexamined
San Diego, CA 12/21/0 -- Illumina has announced that the US Patent and Trademark Office USPTO will reexamine four of the five patents (US Patent Nos. 5,545,531; 5,795,716; 6,355,432 and 6,646,243) that are the subject of Affymetrix's patent infringement suit against the company. In March, a jury ruled in favor...
Two IBO indexes thankful for positive returns
November was another unpredictable month with extreme swings in the equity markets as unrelenting concerns about rising oil prices, consumer spending, credit markets and corporate earnings continued to agonize investors. Over the four days ending November 12 the Dow, S&P 500 and NASDAQ fell 4.9%, 5.3% and 8.5%, respectively. ...
Fed cuts rate again—trick or treat?
October ended with the Federal Open Market Committee lowering the interest rates by a quarter-point and the release of a surprising economic report by the US Commerce Department showing a GDP growth rate of 3.9% for the third quarter. Evidently, a nice treat for investors as the Dow Jones, S&P...
Affymetrix to Webcast Presentation at JPMorgan SMid Cap Conference
SANTA CLARA, Calif. -- Affymetrix Inc. (NASDAQ:AFFX) today announced that John Batty, executive vice president and CFO, will provide a company overview at the JPMorgan SMid Cap Conference on November 5, 2007 in Boston, MA. A live webcast of the presentation will take place at 8:00 a.m. ET. To...
Affymetrix Q3 2007 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions. And our first question comes from the line of Quentin Lai with Robert W. Baird. Quentin Lai - Robert W. Baird Hi, Good afternoon. Could you talk a little bit more about some of the demand that you are seeing for your Gene Expression products,...
Three IBO stock indexes weather a stormy July
Once again volatility ruled the markets in July. The major indexes experienced several extreme swings, both positive and negative, mainly due to conflicting news of positive earnings reports and analyst concerns over the debt markets. In response to subprime and other mortgage debt issues, lenders reported tightening liquidity restrictions in...
Helicos BioSciences Strengthens Executive Management Team in Preparation for Commercial Launch
CAMBRIDGE, Mass. -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today the addition of new members to its executive management team as a key step in building a commercial organization. Chip Leveille has been appointed Vice President of Sales and Marketing and Mark Solakian has been named Vice President and General...
Emerging Markets Consulting, LLC. : Emerging Equity Alerts.
M2 PRESSWIRE-9 January 2007-Emerging Markets Consulting, LLC.: Emerging Markets Consulting, LLC. : Emerging Equity AlertsC1994-2007 M2 COMMUNICATIONS LTD RDATE:09012007 Orlando, FL - Stocks gaining traction in yesterday's trading were Therma-Wave, Inc., (NASDAQ: TWAV), Affymetrix, Inc., (NASDAQ: AFFX), GoAmerica, Inc., (NASDAQ:...
- Next »
- page 1 of 5
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- Nasdaq Stock Market Inc. (52 results)
- FINANCE (51 results)
- Investment (42 results)
- stock (40 results)
- Millipore Corp. (29 results)
- Invitrogen Corp. (24 results)
- Pall Corp. (24 results)
- instrumentation (22 results)
- Alpha (19 results)
- DJIA (17 results)
- Fisher (17 results)
- Thermo Electron Corp. (15 results)
- Molecular Inc. (15 results)
- Harvard (14 results)
- HEALTHCARE (11 results)
- biotechnology (11 results)
- Waters Corp. (11 results)
- Robots (10 results)
- Benefits (8 results)
- HARDWARE (8 results)
- Research In Motion Ltd. (8 results)
- Cell (8 results)
- RAE Systems (8 results)
- Earnings (7 results)
- SOFTWARE (7 results)
- indice (7 results)
- robotics (7 results)
- Pacific (7 results)
- industry (6 results)
- Hitachi Ltd. (6 results)
- analyst (5 results)
- Danaher Corp. (5 results)
- SALES (5 results)
- Strategy (5 results)
- Technologies (5 results)
- financial (4 results)
- revenue (4 results)
- equity (4 results)
- Company (4 results)
- The Dow Chemical Co. (3 results)
- advertisement (3 results)
- SEC (3 results)
- Collaboration (3 results)
- DNA (3 results)
- Massachusetts Institute of Technology (3 results)
- conference (3 results)
- Federal Reserve Board (3 results)
- patent (3 results)
- U.S. Patent and Trademark Office (3 results)
- Illumina Inc. (3 results)
- Incorporated: 1992
- CEO: Mr. Kevin M. King
- Employees: 1,141
Affymetrix develops, manufactures, sells and services consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. Co.'s GeneChip® microarray platform includes: disposable deoxyribonucleic acid probe arrays (chips) consisting of nucleic acid sequences, certain reagents for use with the probe arrays, a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic or genetic information obtained from the probe arrays. Co. also provides microarray technology that includes licenses for fabricating, scanning, collecting and analyzing results from complementary technologies.
Key Competitors
CIO SessionsVision Series on ZDNet
Industry Transcripts by Seeking Alpha
-
Eclipsys Corporation Q3 2008 Earnings Call Transcript
on Nov 20, 2008about ECLP
-
IPG Photonics Corporation Q3 2008 Earnings Call Transcript
on Nov 20, 2008about IPGP
-
Diodes, Inc. Q3 2008 Earnings Call Transcript
on Nov 20, 2008about DIOD
-
Salesforce.com F3Q09 (Qtr End 10/31/08) Earnings Call Transcript
on Nov 20, 2008about CRM
-
Digimarc Corporation Q3 2008 Earnings Call Transcript
on Nov 20, 2008about DMRC
Affymetrix Company Info
Board of Directors
Dr. Stephen P.A. Fodor Ph.D.
Chairman
Mr. Kevin M. King
Dr. Paul Berg Ph.D.
Dr. John D. Diekman Ph.D.
Dr. Susan D. Desmond-Hellmann
Mr. Vernon R. Loucks Jr.
Dr. Robert H. Trice Ph.D.
Mr. Robert P. Wayman
Mr. John A. Young
Contact Information
3380 Central Expressway
Santa Clara, CA
408 731-5000

